Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response
Clinical trial NCT04082260 · UNKNOWN
Trial details
- NCT number
- NCT04082260
- Sponsor
- University Hospital Muenster
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2022-01-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.